|
|
Gene Symbol |
RARRES2 |
|
Aliases |
HP10433, TIG2 |
|
Entrez Gene ID |
|
|
Gene Name |
Retinoic acid receptor responder 2 |
|
Chromosomal Location |
7q36.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a secreted chemotactic protein that initiates chemotaxis via the ChemR23 G protein-coupled seven-transmembrane domain ligand. Expression of this gene is upregulated by the synthetic retinoid tazarotene and occurs in a wide variety of tissues. The active protein has several roles, including that as an adipokine and as an antimicrobial protein with activity against bacteria and fungi. [provided by RefSeq, Nov 2014]
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Retinoic acid receptor responder protein 2, RAR-responsive protein TIG2, chemerin, retinoic acid receptor responder (tazarotene induced) 2, tazarotene-induced gene 2 protein |
|
Function |
Adipocyte-secreted protein (adipokine) that regulates adipogenesis, metabolism and inflammation through activation of the chemokine-like receptor 1 (CMKLR1). Its other ligands include G protein-coupled receptor 1 (GPR1) and chemokine receptor-like 2 (CCRL2). Positively regulates adipocyte differentiation, modulates the expression of adipocyte genes involved in lipid and glucose metabolism and might play a role in angiogenesis, a process essential for the expansion of white adipose tissue. Also acts as a proinflammatory adipokine, causing an increase in secretion of proinflammatory and prodiabetic adipokines, which further impair adipose tissue metabolic function and have negative systemic effects including impaired insulin sensitivity, altered glucose and lipid metabolism, and a decrease in vascular function in other tissues. Can have both pro- and anti-inflammatory properties depending on the modality of enzymatic cleavage by different classes of proteases. Acts as a chemotactic factor for leukocyte populations expressing CMKLR1, particularly immature plasmacytoid dendritic cells, but also immature myeloid DCs, macrophages and natural killer cells. Exerts an anti-inflammatory role by preventing TNF/TNFA-induced VCAM1 expression and monocytes adhesion in vascular endothelial cells. The effect is mediated via inhibiting activation of NF-kappa-B and CRK/p38 through stimulation of AKT1/NOS3 signaling and nitric oxide production. Its dual role in inflammation and metabolism might provide a link between chronic inflammation and obesity, as well as obesity-related disorders such as type 2 diabetes and cardiovascular disease. Exhibits an antimicrobial function in the skin. |
|
|
UniProt |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000162749 |
P19438 |
P19438 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Bipolar Disorder |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS, obesity, insulin resistance (IR), glucose intolerance, dyslipidemia, cardiovascular diseases |
|
Rotterdam inclusion/exclusion criteria |
Direct
|
148 PCOS women and 88 healthy women |
Patients with PCOS showed increased serum chemerin concentrations as compared to healthy women. Individuals with higher chemerin tended to have higher risk for ovarian volume excess in patients with PCOS, regardless of adiposity |
|
|
PCOS, hyperandrogenism (HA), menstrual irregularity, obesity, infertility, impaired glucose tolerance (IGT), insulin resistance (IR), metabolic syndrome, type 2 diabetes mellitus |
|
Rotterdam criteria |
Direct
|
198 PCOS women |
Serum chemerin level is associated with the occurrence of abortion in patients with PCOS. Thus, serum chemerin may serve as a biomarker to identify pregnant women with PCOS who are at particular risk for later abortion, and who may benefit from prevention strategies. |
|
CMKLR1 |
PCOS, hyperandrogenism, chronic anovulation, and insulin resistance |
|
Rotterdam criteria |
Related
|
118 PCOS women and 114 control women |
Serum chemerin levels increased in PCOS women, especially in obese PCOS. HOMA-IR, TC, and leptin are determinants of chemerin levels. Our results suggest that chemerin involved in the pathogenesis of PCOS and metabolicrelated comorbidities, the exact mechanism needs to be further studied. |
|
ITLN1, SERPINA12, SHBG |
PCOS, abdominal adiposity, dyslipidaemia, insulin resistance, risk of type 2 diabetes mellitus (T2DM) |
|
Rotterdam criteria |
Related
|
40 PCOS women,30 control women |
Circulating chemerin was increased in overweight compared with normal weight PCOS patients. The most predictive variables for circulating chemerin in PCOS patients were BMI, FAI and age |
|
ITLN1 |
PCOS, insulin resistance (IR), Type 2 Diabetes |
|
Rotterdam criteria |
Related
|
81 lean and obese women with PCOS, 61 lean and obese controls |
Fat mass seems to be the main determinant factor of increased chemerin and decreased omentin in women with PCOS |
|
|
PCOS, menstrual dysfunction, hyperandrogenism, hyperinsulinemia, insulin resistance, impaired glucose tolerance, type 2 diabetes, dyslipidemia, visceral obesity |
rs17173608 |
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group |
Related
|
150 PCOS women (recruited from an infertility and limited surgical center of Shiraz in southeastern Iran) and 150 control women; Caucasian/Muslim ethnicity for both |
These results suggested that there was a significant association between chemerin rs17173608 polymorphism and the PCOS; but this relationship was affected by obesity status |
|
|
|